Limpa 25 mg+5 mg (Tablet)
Unit Price: ৳ 50.00 (1 x 10: ৳ 500.00)
Strip Price: ৳ 500.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Empagliflozin linagliptin |
| Company | Aristopharma ltd |
| Also available as |
Indications
- Adjunct to diet and exercise
- Improves glycemic control
- Type 2 diabetes mellitus
Pharmacology
- Inhibits DPP-4 enzyme
- Increases active incretin hormones
- Stimulates insulin release
- Decreases glucagon levels
- Reduces hepatic glucose output
- Inhibits Sodium-glucose co-transporter 2 (SGLT2)
- Increases urinary glucose excretion
Dosage & Administration
- Recommended dose of 10mg Empagliflozin and 5mg Linagliptin once daily
- Increased dose up to 25mg Empagliflozin and 5mg Linagliptin once daily
- Assessment of renal function before initiating
Interaction
- Coadministration with diuretics
- Coadministration with Insulin or Insulin secretagogues
- Interference with P-glycoprotein or CYP3A4 Enzymes
Contraindications
- Severe renal impairment
- Hypersensitivity reactions
- End-stage renal disease or dialysis
Side Effects
- Pancreatitis
- Ketoacidosis
- Volume depletion
- Urosepsis and Pyelonephritis
- Hypoglycemia
- Necrotizing Fasciitis of the Perineum
- Genital Mycotic Infections
- Hypersensitivity Reactions
- Severe and Disabling Arthralgia
- Bullous Pemphigoid
- Heart Failure
Pregnancy & Lactation
- Not recommended during the second and third trimesters
- Limited available data
Precautions & Warnings
- Precaution in disease conditions
- Acute pancreatitis risk
- Ketoacidosis risk
- Volume depletion risk
- Urosepsis and Pyelonephritis risk
- Hypoglycemia risk
- Necrotizing Fasciitis of the Perineum risk
- Genital Mycotic Infections risk
- Heart Failure risk
Overdose Effects
- Contact Poison Control Center
- Usual supportive measures
Therapeutic Class
- Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors
Storage Conditions
- Store below 30°C temperature
- Keep away from light and wet place
- Keep out of reach of children